Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Kestra Medical Technologies Ltd's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Kestra Medical Technologies Ltd (KMTS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
64.29 %
Q1 2026
Net Margin
-142.35 %
Q1 2026

Key Findings: Kestra Medical Technologies Ltd vs Its Competitors

  • TTM: Trailing 12-month revenue of 106M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+16.9% annualized vs trailing 12 months).
  • Scale: Kestra Medical Technologies Ltd ranks #55 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.1% of industry market cap.
  • Peer revenue share: Kestra Medical Technologies Ltd accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

KMTS Sales vs. its Competitors, Q1 2026

Kestra Medical Technologies Ltd generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/KMTS/competitors
https://api.csimarket.com/api/v1/companies/KMTS/relationships
https://api.csimarket.com/api/v1/companies/KMTS/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 64.3% for Kestra Medical Technologies Ltd. Kestra Medical Technologies Ltd's share of combined industry revenue moved from 0.02% to 0.03%, a gain of 0.01 percentage points.

Kestra Medical Technologies Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Kestra Medical Technologies Ltd No Yes Yes -
Similar-Size Competitors (10) 60% 90% 80% 11%
Similar Growth & Profitability (8) 0.00 % (0 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 0.00 % (0 of 6)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q1 2026

100%market share
  • Kestra Medical Technologies Ltd100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Kestra Medical Technologies Ltd and its 0 tracked competitors.

See Kestra Medical Technologies Ltd's full market share breakdown »

KMTS Stock Performance relative to its Competitors

KMTS Competitors (weighted) Percent change over the selected range

Kestra Medical Technologies Ltd's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
40%beat U.S.A. 500
Similar-Size
(4 of 10)
40%beat U.S.A. 500
Similar Growth & Profitability
(2 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Kestra Medical Technologies Ltd 14.00 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (5) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Kestra Medical Technologies Ltd's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

KMTS Stock Performance relative to Similar-Size Competitors

KMTS Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

KMTS Stock Performance relative to Similar Growth & Profitability Competitors

KMTS Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Kestra Medical Technologies Ltd's Comment on Competition and Industry Peers

The text addresses forward-looking statements concerning future results, business strategies, technology developments, financing and investment plans, dividend policy, competitive position, industry and regulatory environment, potential growth opportunities, and the impact of competition. It notes that these statements involve risks and uncertainties that could cause actual outcomes to differ materially from those anticipated.